Tokyo, Nov. 6 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000059641) titled 'Effectiveness of Dynamic Hamstring Stretching Using a Hybrid Training System (HTS)' on Nov. 5.
Study Type:
Interventional
Study Design:
Basic Design - Cross-over
Randomization - Randomized
Blinding - Open -no one is blinded
Control - Placebo
Primary Sponsor:
Institute - Kurume Univercity
Condition:
Condition - Healthy Volunteers
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - Evaluation of Flexibility through Dynamic Stretching with an Electrical Stimulation Device
Basic objectives2 - Efficacy
Intervention:
Interventions/Control_1 - Electrical stimulation devices will be attached to both thighs, but stimulation will be applied only to one leg, while the other leg will serve as the control without stimulation. Dynamic stretching will then be performed under these conditions.
After a one-week washout period, electrical stimulation will be applied to the opposite leg, and dynamic stretching will again be performed.
Flexibility will be assessed before and after stretching in each condition.
Interventions/Control_2 - Electrical stimulation devices will be attached to both thighs, but stimulation will be applied only to one leg, while the other leg will serve as the control without stimulation. Dynamic stretching will then be performed under these conditions.
After a one-week washout period, electrical stimulation will be applied to the opposite leg, and dynamic stretching will again be performed.
Flexibility will be assessed before and after stretching in each condition.
Eligibility:
Age-lower limit - 20
years-old
=
Gender - Male and Female
Key inclusion criteria - Participants eligible for this study will be those who meet all of the following criteria: individuals who are healthy, have no current acute illness requiring treatment and are able to perform exercise, are between 18 and 65 years of age at the time of obtaining consent, and have provided written informed consent to participate in the study.
Key exclusion criteria - Participants who meet any of the following conditions will be excluded from this study: those diagnosed with coronary artery disease or neuromuscular disorders; those currently receiving anticoagulant, antiplatelet, or other medications affecting bleeding tendency; those under treatment for malignant diseases, including metastatic bone tumors; those with dementia that interferes with activities of daily living (other than grade 1-2 on the Dementia Scale for Independence in Daily Living of the Elderly with Dementia) and those who will exceed 65 years of age by the completion of study participation.
Target Size - 16
Recruitment Status:
Recruitment status - Open public recruiting
Date of protocol fixation - 2025 Year 10 Month 01 Day
Date of IRB - 2025 Year 09 Month 02 Day
Anticipated trial start date - 2025 Year 10 Month 15 Day
Last follow-up date - 2026 Year 12 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000067420
Disclaimer: Curated by HT Syndication.
